|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-IPR-14005620 |
|
Date of registration:
|
2014-12-04 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The effect of dexmedetomidine on postoperative pain in elder patients
|
|
Scientific title:
|
The effect of dexmedetomidine on postoperative pain in elder patients |
|
Date of first enrolment:
|
2014-12-15 |
|
Target sample size:
|
Control Group:29;Trial Group:29; |
|
Recruitment status: |
Pending |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=10010 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Post-market
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Wang Dongxin
|
|
Address:
|
Peking University First Hosptal, Xishiku Street N0. 8, Beijing China
|
|
Telephone:
|
01083575138 |
|
Email:
|
wangdongxin@hotmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Mu Dongliang
|
|
Address:
|
Peking University First Hosptal, Xishiku Street N0. 8, Beijing China
|
|
Telephone:
|
138107012725 |
|
Email:
|
120914921@qq.com |
|
Affiliation:
|
Peking University First Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. patients who undertake selective major surgery;
2. age between 60 and 85 years-old.
Exclusion criteria: 1. History of mental disease;
2. history of sick sinus syndrom;
3. bradycadia (HR less than 50bpm);
4. II or III AVB;
5. severe hepatic disease (more than Child-Pugh C);
6. severe renal disease (dialysis);
7. body weight less than 50Kg
Age minimum:
60
Age maximum:
85
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
postoperative pain
|
|
Intervention(s)
|
|
Control Group:patient controlled analgesia:morphine 0.5mg/ml, background infusion time 1ml/h, block time 6min, single bolus 2ml;Trial Group:patient controlled analgesia:morphine 0.5mg/ml+dexmeditomidate 2ug/ml, background infusion time 1ml/h, block time 6min, single bolus 2ml;
|
|
Primary Outcome(s)
|
|
postoperative consumption of morphine;
|
|
Source(s) of Monetary Support
|
|
Peking University First Hospital
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|